|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||
| Interest-bearing deposits in other financial institutions | ||||||||||||||||||
| Federal funds sold | ||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||
| Securities available for sale, at fair value | ||||||||||||||||||
| Loans held for sale | ||||||||||||||||||
| Loans, less allowance for credit losses of $14,315 at December 31, 2022 and $14,656 at December 31, 2021 | ||||||||||||||||||
| Loans, less allowance for credit losses of $16,075 at September 30, 2023 and $14,315 at December 31, 2022 | ||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||
| Premises and equipment, less accumulated depreciation | ||||||||||||||||||
| Restricted stock | ||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||
| Financing lease right-of-use assets | ||||||||||||||||||
| Other investments | ||||||||||||||||||
| Deferred income taxes, net | ||||||||||||||||||
| Bank owned life insurance | ||||||||||||||||||
| Other real estate owned, net | ||||||||||||||||||
| Core deposit intangible, net | ||||||||||||||||||
| Goodwill | ||||||||||||||||||
| Other assets | ||||||||||||||||||
| Total assets | ||||||||||||||||||
| LIABILITIES | ||||||||||||||||||
| Deposits: | ||||||||||||||||||
| Non-interest-bearing demand | ||||||||||||||||||
| Interest-bearing demand | ||||||||||||||||||
| Savings and money market | ||||||||||||||||||
| Time, $100,000 or more | ||||||||||||||||||
| Other time | ||||||||||||||||||
| Time | ||||||||||||||||||
| Deposits, Total | ||||||||||||||||||
| Accrued interest payable on deposits | ||||||||||||||||||
| Short-term borrowings with the Federal Home Loan Bank | ||||||||||||||||||
| Long-term borrowings with the Federal Home Loan Bank | ||||||||||||||||||
| Subordinated notes payable, net | ||||||||||||||||||
| Other borrowings | ||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||
| Financing lease liabilities | ||||||||||||||||||
| Other liabilities | ||||||||||||||||||
| Total liabilities | ||||||||||||||||||
| STOCKHOLDERS' EQUITY | ||||||||||||||||||
| Common stock, par value $0.01, authorized 40,000,000 shares, issued and outstanding 17,985,577 as of September 30, 2023 and 17,973,724 as of December 31, 2022, including 9,338 nonvested shares as of September 30, 2023 and 18,669 nonvested shares as of December 31, 2022 | ||||||||||||||||||
| Surplus | ||||||||||||||||||
| Retained earnings | ||||||||||||||||||
| Noncontrolling interest in consolidated subsidiaries | ||||||||||||||||||
| Accumulated other comprehensive loss, net of tax | ||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||
Loading...
